Matthew E Wintle
Overview
Explore the profile of Matthew E Wintle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Minshall M, Oglesby A, Wintle M, Valentine W, Roze S, Palmer A
Value Health
. 2008 Feb;
11(1):22-33.
PMID: 18237357
Objectives: This analysis provides an early estimate of the cost-effectiveness of adjunctive exenatide in treating type 2 diabetes mellitus in the United States. Data from pivotal phase III 30-week clinical...
2.
Klonoff D, Buse J, Nielsen L, Guan X, Bowlus C, Holcombe J, et al.
Curr Med Res Opin
. 2007 Dec;
24(1):275-86.
PMID: 18053320
Background: Exenatide, an incretin mimetic for adjunctive treatment of type 2 diabetes (T2DM), reduced hemoglobin A(1c) (A1C) and weight in clinical trials. The objective of this study was to evaluate...
3.
Buse J, Klonoff D, Nielsen L, Guan X, Bowlus C, Holcombe J, et al.
Clin Ther
. 2007 Mar;
29(1):139-53.
PMID: 17379054
Background: Exenatide, an incretin mimetic for adjunctive treatment of type 2 diabetes mellitus (T2DM), reduced glycosylated hemoglobin (HbA(1c)) and weight in 30-week placebo-controlled trials. Some patients were followed up in...